# Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients

> **NCT04222686** · PHASE4 · COMPLETED · sponsor: **Yaounde Central Hospital** · enrollment: 23 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Perindopril Arginine
- **DRUG:** Losartan Potassium

## Key facts

- **NCT ID:** NCT04222686
- **Lead sponsor:** Yaounde Central Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-20
- **Primary completion:** 2018-02-15
- **Final completion:** 2018-04-30
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2020-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04222686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04222686, "Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04222686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*